Latest filings (excl ownership)
15-12G
Securities registration termination
1 Mar 24
SC TO-T/A
Third party tender offer statement (amended)
21 Feb 24
EFFECT
Notice of effectiveness
21 Feb 24
25-NSE
Exchange delisting
20 Feb 24
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 24
POS AM
Prospectus update (post-effective amendment)
20 Feb 24
8-K
Completion of Acquisition or Disposition of Assets
20 Feb 24
SC 14D9/A
Tender offer solicitation (amended)
20 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
20 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
14 Feb 24
SC 14D9/A
Tender offer solicitation (amended)
14 Feb 24
SC 14D9/A
Tender offer solicitation (amended)
19 Jan 24
SC TO-T/A
Third party tender offer statement (amended)
19 Jan 24
SC TO-T/A
Third party tender offer statement (amended)
10 Jan 24
SC 14D9/A
Tender offer solicitation (amended)
10 Jan 24
SC 14D9
Tender offer solicitation
27 Dec 23
SC TO-T
Third party tender offer statement
27 Dec 23
SC14D9C
Written communication relating to third party tender offer
20 Dec 23
SC14D9C
Written communication relating to third party tender offer
14 Dec 23
SC TO-C
Information about tender offer
12 Dec 23
SC14D9C
Written communication relating to third party tender offer
12 Dec 23
SC14D9C
Written communication relating to third party tender offer
12 Dec 23
8-K
Tender and Support Agreement
12 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Icosavax Reports Third Quarter 2023 Financial Results and Provides Corporate Update
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update
14 Aug 23
8-K
Regulation FD Disclosure
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
9 Jun 23
8-K
Entry into a Material Definitive Agreement
23 May 23
424B5
Prospectus supplement for primary offering
23 May 23
8-K
Regulation FD Disclosure
22 May 23
10-Q
2023 Q1
Quarterly report
10 May 23
8-K
Icosavax Reports First Quarter 2023 Financial Results and Provides Corporate Update
10 May 23
ARS
2022 FY
Annual report to shareholders
19 Apr 23
DEFA14A
Additional proxy soliciting materials
19 Apr 23
DEF 14A
Definitive proxy
19 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
8-K
Icosavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
30 Mar 23
8-K
Other Events
13 Dec 22
Latest ownership filings
SC 13D/A
Qiming U.S. Healthcare GP II, LLC
21 Feb 24
SC 13D/A
RA CAPITAL MANAGEMENT, L.P.
21 Feb 24
4
Rajeev M. Shah
20 Feb 24
4
Adam K. Simpson
20 Feb 24
4
Amin Khan
20 Feb 24
4
Ann M Veneman
20 Feb 24
4
Cassia Cearley
20 Feb 24
4
HEIDI FIELDS
20 Feb 24
4
Jim Wassil
20 Feb 24
4
Thomas Joseph Russo
20 Feb 24
4
John W. Shiver
20 Feb 24
4
MARK MCDADE
20 Feb 24
4
Niranjan Kanesa-thasan
20 Feb 24
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 24
SC 13G
Pentwater Capital Management LP
14 Feb 24
SC 13G
T. Rowe Price Investment Management, Inc.
14 Feb 24
SC 13G
PLATINUM INVESTMENT MANAGEMENT LTD
13 Feb 24
SC 13G/A
BlackRock Inc.
7 Feb 24
4
Adam K. Simpson
2 Feb 24
SC 13G
BlackRock Inc.
2 Feb 24
4
Adam K. Simpson
23 Jan 24
SC 13G/A
FMR LLC
10 Jan 24
4
Niranjan Kanesa-thasan
5 Jan 24
4
Adam K. Simpson
4 Jan 24
144
Notice of proposed sale of securities
4 Jan 24
4
Adam K. Simpson
22 Dec 23
4
Thomas Joseph Russo
22 Dec 23
4
Niranjan Kanesa-thasan
22 Dec 23
4
Cassia Cearley
22 Dec 23
144
Notice of proposed sale of securities
21 Dec 23
144
Notice of proposed sale of securities
21 Dec 23
144
Notice of proposed sale of securities
20 Dec 23
144
Notice of proposed sale of securities
20 Dec 23
144
Notice of proposed sale of securities
20 Dec 23
144
Notice of proposed sale of securities
20 Dec 23
144
Notice of proposed sale of securities
20 Dec 23
4
Cassia Cearley
15 Dec 23
144
Notice of proposed sale of securities
13 Dec 23
SC 13D/A
ADAMS STREET PARTNERS LLC
24 Nov 23
4
Adam K. Simpson
1 Aug 23